Earle F Burgess

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Locally Advanced

Tyrosine Kinase

Radical Prostatectomy

Top Venues

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Peter H O'Donnell, Matthew I Milowsky, Daniel P Petrylak, Christopher J Hoimes, Thomas W Flaig, Nataliya Mar, Helen H Moon, Terence W Friedlander, Rana R McKay, Mehmet Asim Bilen, Sandy Srinivas, Earle F Burgess, Chethan Ramamurthy, Saby George, Daniel M Geynisman, Sergio Bracarda, Delphine Borchiellini, Lionnel Geoffrois, Jose Pablo Maroto Rey, Christiano Ferrario, Anne-Sophie Carret, Yao Yu, Maria Guseva, Blanca Homet Moreno, Jonathan E Rosenberg
Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Landon C Brown, Jason Zhu, Elizabeth Mauer, Stephanie N Thiede, Lisa Macera, Michelle M Stein, Timothy Taxter, Derek Raghavan, Earle F Burgess
RNA-Based Homologous Recombination Deficiency Signature Detects Homologous Recombination Deficiency-RNA+ Patients With and Without Homologous Recombination Repair Gene Pathogenic Alterations in Men With Prostate Cancer. JCO precision oncology 7 (2023)
Landon C Brown, Jason Zhu, Elizabeth Mauer, Stephanie N Thiede, Lisa Macera, Michelle M Stein, Timothy Taxter, Derek Raghavan, Earle F Burgess
RNA-Based Homologous Recombination Deficiency Signature Detects Homologous Recombination Deficiency-RNA+ Patients With and Without Homologous Recombination Repair Gene Pathogenic Alterations in Men With Prostate Cancer. JCO precision oncology 7 (2023)